Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT01884051
Hormonal, Metabolic, and Signaling Interactions in PAH
Sponsor: Vanderbilt University Medical Center
View on ClinicalTrials.gov
Summary
Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.
Official title: Hormonal, Metabolic, and Signaling Interaction in Pulmonary Arterial Hypertension
Key Details
Gender
All
Age Range
Any - 90 Years
Study Type
OBSERVATIONAL
Enrollment
1899
Start Date
2012-09
Completion Date
2032-07
Last Updated
2025-09-16
Healthy Volunteers
Yes
Conditions
Locations (1)
Vanderbilt University Medical Center
Nashville, Tennessee, United States